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Abstract
Background: To report patients with age-related macular degeneration and atypical central retinal pigment
epithelium (RPE) defects not attributable to geographic atrophy (GA) or RPE-tears with overlying preserved
photoreceptor layers.
Methods: Multimodal imaging case-series evaluating the course of atypical RPE- defects in patients with AMD
using Color fundus images, Optical coherence tomography (OCT), OCT-Angiography, fundus autofluorescence (FAF)
and fluorescein-angiography (FA).
Results: Ten patients were identified. Three patients had a prior RPE-rip and were excluded. Seven patients with a mean
follow-up period of 47 ± 38 months after the occurrence of the RPE-defect were included (age range 71–87 years). Mean
distance Best corrected visual acuity (BCVA) at initial presentation was 0.36 ± 0.29logMAR and at last follow-up
visit 0.51 ± 0.43logMAR. Patients presented with clinically apparent GA on funduscopy and FAF, but preserved
photoreceptor layers on optical coherence tomography (OCT). On FA there was early hyperfluorescence and
late pooling visible. Over time, migration of RPE/drusenoid material right above the Bruch’s membrane with
concomitant decrease of hypoautofluorescence was detectable in 4 cases. An enlargement of the RPE-defect
was apparent in the remaining 3 cases. The majority (n = 4) showed a drusenoid pigment epithelium
detachment (PED) preceding the lesion.
Conclusions: Beside GA and characteristic RPE-tears, another atypical form of RPE-defect with overlying
preserved photoreceptor layers are found in AMD. This so far disregarded subgroup of patients present with
reasonable visual function and long-term survival of photoreceptors layers. Repair mechanisms such as
ingrowth of RPE/drusenoid material and persistent subretinal fluid (SRF), but also a RPE-independent visual
cycle for cone photopigment within the neurosensory retina may contribute to their favorable course.
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Background
Classic retinal pigment epithelium (RPE) tears in age-
related macular degeneration (AMD) usually occur in
patients with a fibrovascular pigment epithelium detach-
ment. In respective cases a RPE tear may occur spontan-
eously, after administration of intravitreal anti- VEGF, or
after photodynamic therapy [1–4]. These RPE-tears result
in poor visual function and loss of photoreceptors with
the development of fibrous tissue and enlargement of
the RPE defects [5, 6]. Beside the description of these
characteristic RPE-tears, a few case reports of less
characteristic, central RPE-defects with neurosensory
retinal elevation and subretinal fluid overlying the PED
exist in literature [7–10]. Cases with such atypical
RPE-defects had AMD or suspected central serous
chorioretinopathy (CSC) without definite evidence of a
CNV-membrane and maintained reasonable visual
function over a longer period of time [7–10].
Subretinal migration of RPE/drusenoid material was
found in some of these cases, resembling a possible
repair mechanism [8, 9, 11–13]. Most of respective cases
were described before the OCT era, and the preservation
of the photoreceptors overlying the area of RPE-defects
was therefore only presumed based on the maintenance
of reasonable visual function.
A detailed, coherent description of such cases with a
long term follow up using multimodal imaging is still
missing. The aim of this study is to describe patients
presenting with atypical, central RPE-defects not attrib-
utable to classic RPE-tears or geographic atrophy (GA)
that retain intact photoreceptor layers and discuss
possible pathomechanism.
Methods
Patient selection and setting
This retrospective, observational case series collected cases
from tertiary referring institutions: 1. Inselspital, University
Hospital Bern, Bern, Switzerland, 2. Retina clinic, University
of Sao Paulo, Brazil, 3. Stein Eye Institute, Los Angeles,
USA, 4. Zealand University Hospital, Denmark, 5. Shroff
Eye Center, New Delhi, India, 6. Vitreous Retina Macula
Consultants of New York, USA, 7. University Paris Est,
CHI, Creteil, France, and 8. University Vita-Salute, IRCCS
Ospedale San Raffaele, Milan, Italy.
Patients were included if they had been diagnosed with
AMD and presented with a center-involving RPE-defect
with intact overlying photoreceptor layers and a mini-
mum follow up of 6 months. Spectral domain optic
coherence tomography (SD-OCT) had to reveal a center
involving RPE-defect and a retained external limiting
membrane (ELM) and ellipsoid zone (EZ) overlying the
defect. On funduscopy, clinically apparent central geo-
graphic atrophy (GA) had to be present. Patients with
evidence of rippling/retracted RPE at the margins of the
lesion and with a fibrovascular PED with/without a history
of anti-VEGF administration preceding the RPE-defect
were excluded. Demographic and clinical data were
collected and image analysis included color fundus and
red-free photography, SD-OCT (Heidelberg Engineering,
Germany and Zeiss, Zeiss AG, Germany), near-infrared
reflectance, blue (488 nm) fundus autofluorescence (FAF)
and fluorescein angiography (FA). Whenever available
NIR (787 nm)-FAF and OCT-angiography (Heidelberg
Engineering and Nidek) were investigated as well. Data
are reported in mean, standard deviation (mean ± SD),
ranges and frequencies.
Results
Ten patients were identified; three had a prior RPE rip
and were excluded from the study. Thus, seven eyes from
7 patients (5 females) met the inclusion criteria. Demo-
graphic characteristics, ocular manifestation and adminis-
tered treatment of each patient can be found in Table 1.
Age ranged from 71–87 years. Mean distance BCVA at
initial presentation was 0.36 ± 0.29logMAR and at last
follow-up visit 0.51 ± 0.43logMAR (Table 1). Mean follow-
up period was 47 ± 38 months. Patients presented with
clinically apparent central geographic atrophy on fundus-
copy. FAF-imaging showed corresponding hypoautofluor-
ence with stippled hyperautofluorescent areas scattered
within the hypoautofluorescent lesion (Figs. 1, 2 and 3).
SD-OCT revealed preserved ELM and EZ overlying the
center involving RPE-defect throughout the entire obser-
vation period (Figs. 1, 2, 3 and 4). But while the ELM
remained unchanged, the EZ decreased in thickness over
time. The majority of eyes (n = 5) had subretinal fluid
(SRF) overlying the RPE-defect (Figs. 1 and 3). Intact ELM
and EZ directly adjacent to the Bruch’s membrane were
found in the remaining 2 eyes (Fig. 2). On fluorescein-
angiography there was an early hyperfluorescence corre-
sponding to the RPE-defect and pooling in the late frames
(Fig. 3). None had a definite evidence of exudative AMD.
The absence of a CNV was confirmed by OCT-A in 3
cases (Fig. 3). None of the cases showed retracted RPE
(Figs. 1, 2, 3 and 4).
The prior lesion preceding the RPE-defect was a druse-
noid, avascular PED in the majority of the cases (n = 4)
(Fig. 1; Table 1). Despite the absence of a definite chor-
oidal neovascularization (CNV), 4 eyes with SRF received
intravitreal anti-VEGF injections (Table 1). SRF (n = 5)
persisted in 3 cases and the remaining 2 cases showed
SRF resolution after 12 and 7 months, respectively.
Resolution/persistence of SRF did not correspond to anti-
vascular endothelial growth factor (VEGF) treatment
(Table 1). Migration of RPE/drusenoid material right
above the Bruch’s membrane with concomitant de-
crease of hypoautofluorescence and window defect
was detectable in 4 cases (Figs. 1 and 2, Table 1). In 2
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Fig. 1 Top: 2010: Initial presentation with drusenoid pigment epithelium detachment (PED). 2011: spontaneous resolution of PED. 2013: Spontaneous
RPE aperture. The OCT reveals an RPE defect with SRF. The overlying photoreceptors are intact. Fundus autofluorescence (FAF) and fluorescein angiography
(FA) shows hypoautofluorescence and pooling corresponding to RPE defect, respectively. 2014 Resolution of SRF after anti-VEGF treatment. Intact ellipsoid
zone and ELM directly attached to the Bruch’s membrane. Enhanced choroidal signaling due to the absence of RPE is evident. Some ingrowth of
iso-autofluorescent material is already notable on FAF (red, bold arrow). Also SD-OCT reveal some hyperreflective material (thin, red arrow) 2015
Ingrowth and regeneration of RPE/drusenoid material with consecutive decrease of enhanced choroidal signaling (thin, red arrow), hypoautofluorescence
(red, bold arrow) and window defect Red (thin and bold) arrows denote hyperreflective and hyperFAF material, suggestive of potential ingrowth of
drusenoid/RPE material
Table 1 Clinical presentation and ocular characteristics of included patients
# Eye Lesion prior
to RPE defect
F/u (mo) BL BCVA Final
BCVA
Treatment after
RPE defect
SRF duration
(month)
OCT-A HypoFAF
area F/u
Mi-gration RPE defect
(OCT)
Presentation
Fellow eye
1 OD drusenoid
PED
36 20/20 20/20 3× bevacizumab 12 - ↓ + ↓ Drusen, RPD
2 OS N.A. 60 20/160 20/200 none 0 - ↓ + ↓ Occult CNV
3 OS N.A. 120 20/50 20/200 2× retaane, 37×
ranibizumab
persistent No NV
network
↑ - ↑ Drusenoid PED,
IRC, atrophy
4 OD drusenoid
PED
60 20/40 20/125 32× ranibizumab persistent No NV
network
↑ - ↑ Drusenoid PED,
RPD
5 OD drusenoid
PED
12 20/25 20/25 2× ranibizumab 7 - ↓ + ↓ Drusen
6 OS drusenoid
PED
36 20/40 20/63 none persistent - ↑ - ↑ St.p. macular
hole, Drusen
7 OS Drusen 6 20/70a 20/30 none 0 No NV
network
↓ + ↔ Fibrovascular
scar, Drusen
Clinical characteristics of the 7 included patients all diagnosed with AMD and presenting with a center-involving RPE defect with intact overlying photoreceptor
layers and a minimum of follow up of 6 months. All included cases were treatment naïve without evidence of a choroidal neovascularization when diagnosed
RPE retinal pigment epithelium, BCVA best corrected visual acuity, SRF subretinal fluid, BL Baseline, F/u duration of follow up between initial presentation of
RPE-defect and last visit, FAF fundus autofluorescence, IRC intraretinal cysts, NV neovascular, Migration migration of subretinal drusenoid/RPE material
ainitial BCVA was performed prior to cataract surgery
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cases (case 2 and case 7) ingrowth was associated with
visual acuity improvement. An increase of the RPE-
defect size was apparent in the 3 remaining cases
without tissue migration, all had persistent SRF and
no evidence of migration of RPE/drusenoid material
(Fig. 3). Figure 4 displays the SD-OCT images of all
included patients.
Representative cases
Case 1
A patient presented with a drusenoid PED in 2010 (BCVA
20/20, Fig. 1). In 2011 there was spontaneous resolution
of the PED and BCVA remained stable at 20/20. In April
2013 a spontaneous RPE-defect with overlying intact pho-
toreceptors layers and SRF developed (BCVA 20/20). The
Fig. 2 2010: A circumscribed RPE atrophy is noted on color fundus with corresponding window defects visible on FA. 2011: The now performed
FAF and SD-OCT highlights the loss of RPE with corresponding hypo autofluorescence on FAF and enhanced choroidal signaling on SD-OCT. The
ELM, ellipsoid zone and the interdigitation zone are attached to the Bruch’s membrane. 2012 and 2013: Decrease in window defect on FA,
hypoautofluorescence on FAF and enhanced choroidal signaling on SD-OCT is noted. Ingrowth of RPE/drusenoid material (red, thin arrow) is
evident overlaid by PR layers
Fig. 3 Initial presentation 2005 shows a large RPE atrophy on color fundus with corresponding hypoautofluorescence on FAF. A window defect
with evidence of pooling within the subretinal space is visible on FA without a definite evidence of a CNV. 2007: Follow up images 2007 reveal a
central RPE defect, SRF and a preserved photoreceptor (PR) layer. Obvious shedding of the PR-outer segments is evident. 2009: The RPE defect
has increased in size, the SRF has persisted despite anti-VEGF therapy. The PR are present. 2015 Increase of the RPE defect, the overlying PR are
still present but the lengths are reduced. The OCT angiography of the choriocapillaries confirms the absence of a CNV
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patient received 3 monthly intravitreal bevacizumab
injections without any visible change in the amount of
SRF (BCVA 20/20). The treatment was stopped and
the patient was observed. Spontaneous SRF resolution
was noted November 2013. The intact EZ and ELM
was now directly attached to the Bruch’s membrane
(Fig. 1). Ingrowth of iso-and-hyperautofluorescent
material was noted on FAF (Fig. 1, red arrows). Over
the next 2 years, ingrowth and regeneration of RPE/
drusenoid material with consecutive decrease of en-
hanced choroidal signaling, hypoautofluorescence and
window defect was found. During this period BCVA
remained stable at 20/20.
Case 2
A patient presented with a circumscribed RPE-defect
and a corresponding window defect on FA without
evidence of retracted RPE in the left eye in 2010 with a
BCVA of 20/160 (Fig. 2). The SD-OCT performed
initially in April 2011 revealed the RPE-defect with
enhanced choroidal signaling and intact ELM and EZ
directly attached to the Bruch’s membrane (Fig. 2). Sub-
retinal migration of hyperreflective material along the
Bruch’s membrane with decrease of the hypo-FAF and
the window defect in FA over the following 4 months
was seen. During this period, the BCVA improved from
20/160 to 20/125 (Fig. 2). Throughout the next two
years ELM and EZ remained intact, but the BCVA
slowly dropped from 20/125 to 20/200.
Case 3
In 2005 a patient noted a visual acuity decrease in the left
eye. BCVA was 20/50 and soft, confluent drusen and a
large, central RPE-defect were seen funduscopically
(Fig. 3). FA showed early hyperfluorescence and late pool-
ing without definite evidence of a CNV and without
evidence of blockage due to retracted RPE (Fig. 3). The
patient received a juxtascleral Retaane injection. BCVA
remained unchanged. Over the next 2 years another
Retaane injection and 3 intravitreal ranibizumab injections
were administered. 2007 BCVA was 20/63 and SD-OCT
revealed a central, large RPE-defect, SRF and preserved
photoreceptor layers. Over the next 2 years the RPE-
defect enlarged, and SRF persisted despite multiple ranibi-
zumab injections. The ELM remained intact, but the EZ
decreased in thickness and a reduction in photoreceptor
outer segment shedding was noted (Fig. 3). BCVA was 20/
80. 2013 intravitreal ranibizumab injections were stopped.
The RPE-defect further enlarged and 2015 BCVA was 20/
100. The OCT-A performed 2015 confirmed the absence
of a CNV membrane in the left eye (Fig. 3).
Discussion
We here describe a so far disregarded presentation of
AMD with atypical RPE-defects not attributable to GA or
RPE-tears with preserved overlying photoreceptor-layers.
The majority had SRF which persisted or resolved inde-
pendent to intravitreal treatment. This fact strengthens
the assumption that not a CNV was the underlying
cause of SRF but rather the local loss of the RPE and
therefore the inability to pump ions and fluid out of the
subretinal space. RPE-defect enlargement was associ-
ated with persistent SRF and lack of migration of
subretinal RPE/drusenoid material, whereas migration
of subretinal RPE/drusenoid material correlated with
resolution/absence of SRF.
RPE-tears in the classical sense were first reported by
Hoskin et al. and are characteristically found in patients
Fig. 4 Depicts the presentation on OCT of each included patient
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with fibrovascular PED [14, 15]. They can occur spontan-
eously or may be related to various treatments [13, 15–18].
Contractile and hydrostatic forces inherent within the vas-
cularized PED are described to be the most likely factors
leading to the evolution of a RPE-tear, which usually in-
volves the photoreceptor layers [15]. In general, RPE-tears
in exudative AMD have a poor visual prognosis. Despite
this fact, some cases with subfoveal RPE-tears and pre-
served visual function and retained photoreceptor layers
were reported [11, 12, 19]. But our cases lacked character-
istics of typical RPE-tears, which are typically found near
the base of the fibrovascular PED with retracted RPE.
There was also no evidence of exudative AMD, lacking the
causative tractional forces of the CNV membrane. Further
reasonable visual function and retained photoreceptors
overlying the RPE-defect were evident and could be
preserved over a long period of time.
GA may be the other well-known condition in AMD
presenting with large RPE-defects. In contrast to our
findings, RPE atrophy is associated with photoreceptor
loss in GA. In fact, the loss of photoreceptors, in
particular the loss of the rods and cone outer segments
precedes RPE atrophy in GA and the area of photo-
receptor loss may be much larger than the area of RPE
atrophy [20–23]. Typical morphological patterns such as
subsidence and thinning of the outer plexiform layer
and loss of the ELM, the EZ- and the interdigitation
zone is associated with RPE atrophy in GA [24].
The first report describing two patients with similar
atypical RPE-defects was published 1987 [7]. These so
called “blow-outs” of the RPE demonstrated intense leak-
age through the defects on FA. The resulting vision was
20/30 and 20/70, respectively. Similar to our cases and in
contrast to characteristic RPE-tears, the RPE-defects were
rather found at the dome of the detachment and not along
the margins of the PED [7]. A case report published 1990
found two patients with spontaneous RPE-tears in long-
standing serous RPE-detachments without evidence of a
CNV who could keep a visual acuity of at least 20/40 over
an observation period of 3 years after the rip had occurred
[8]. During follow up, pigment migration along the tear
edges was noted [8]. A RPE-tear in a patient with a mixed
serous/drusenoid PED with intact photoreceptor layers
and a visual acuity of 20/25 during the course of observa-
tion has recently been described [9]. Also in this patient,
no definite evidence of a CNV was found [9]. Another
report published 2014 showed spontaneous bilateral RPE-
defects. After 2.5 years of follow-up the overlying photo-
receptor layers were still intact and visual acuity were 6/9
and 6/6, respectively [25]. These examples all describe
atypical, subfoveal RPE-defects with long-term survival of
the overlying photoreceptors in patients with AMD and
may depict the same disease process described here. A re-
cent report described so called RPE-apertures [10]. Similar
to our cases, well circumscribed discontinuity of the RPE
without retracted RPE was found and avascular PEDs
preceded respected lesions [10]. They enlarged homoge-
neously over time and focal hyperautofluoscent lesions
were found prior to the onset [10]. Given the fact that 4 of
our cases showed a drusenoid PED preceding the RPE-
defect and hyperautofluosescent lesions, it is very likely
that the RPE-apertures described, resemble the same dis-
ease process. However, none of the previously reported
RPE apertures revealed migration of subretinal material.
Although 4 of our cases (case 2, 4 and 5, 6) had hyper-
autofluorescent lesions, an AMD related genesis, in
particular a drusenoid PED rather than an underlying
CSC or pattern dystrophy seems most likely as the age
ranged between 71 and 87 years and they had large, soft
drusen in the study as well as in the fellow eyes. How-
ever, a pattern dystrophy, CSC, Morbus Stargardt or a
former Morbus Best may also be associated with such
RPE alterations and cannot be excluded as possible
underlying diseases.
Apparently photoreceptors seem capable to survive
without normal RPE. A previous report already specu-
lated that RPE may not obligatory be essential for the
survival of photoreceptor-cells [8]. In AMD, rods seem
more vulnerable, while cones seem to survive for longer
periods also in the absence of outer or inner segments
[23, 26, 27]. The reason for the earlier involvement of
rods relative to cones in AMD is unknown, however it
was speculated that the localized deficiency of retinoid,
which is essential for photoreceptor survival, may be an
underlying cause leading to impaired retinoid transfer
from blood to the RPE due to debris accumulation [22].
Another explanation may be found in a study performed
2002, which demonstrated that within the neurosensory
retina of non-human vertebrates there is an RPE-
independent visual cycle for cone photopigment regener-
ation and day-light vision [28]. In accordance with those
findings our long-term observation of preserved photo-
receptor layers and reasonable visual function might uphold
the hypothesis that (at least) the cone photopigment regen-
eration can occur independently from the RPE. The same
previous study however also speculated that photoreceptors
may be still apposed to some remaining RPE cells [8].
Unfortunately even in the OCT era, this question cannot
be conclusively determined; additional image modalities
such as polarization sensitive OCT or adaptive optics OCT
may be able to further elaborate this question.
Beside the proposed mechanisms, other potential
mode of actions may contribute to the long-term sur-
vival: Four of our cases showed migration of subretinal
RPE/drusenoid material. The migration and recovery of
pigmented tissue was initially noted and described 1988
in 4 patients after classic RPE-tears and it was specu-
lated that it might resemble a repair mechanism [5]
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Bressler et al. also noticed, migration of pigmented
material in both reported patients [8]. Caramoy et al.
observed 2012 that patients with RPE-tears revealed
migration and repopulation of RPE as shown in FAF and
SD-OCT. However, this migrated RPE did not form a
functional RPE-layer. They concluded that a small RPE-
defect may be repaired by cell proliferation, but that
respective RPE-cell proliferation is not sufficient in cov-
ering larger defects [29]. Mukai et al. recently described
potential repair mechanisms in patients after RPE-tears
and postulated 2 main modes of actions: The first mech-
anism included persistent SRF after the RPE-tear leading
to thickened proliferative tissue at the affected area. The
second mechanism was described to present with early
and complete resolution of the SRF, the outer retina
directly being attached to the Bruch’s membrane and
attenuation of the normal hyperreflective band attribut-
able to “normal” RPE [12]. The RPE/drusenoid material
found in this report was also postulated to represent
RPE-regeneration [12]. This assumption is strengthened
by the fact that animal models have proven RPE-
regeneration [8, 12, 30]. Accordingly, our cases showed
SRF resolution and 2 cases had concomitant visual func-
tion improvement accompanied with the ingrowth of
RPE/drusenoid material above the Bruch’s membrane,
whereas in cases of persistent SRF no ingrowth was
noted. Further, in cases of persistent SRF and no RPE
ingrowth, enlargement of the RPE-defects has been
observed. As the resolution of SRF was associated with
the presence and ingrowth of the subretinal material it is
likely that the tissue resembles RPE-regeneration, as pre-
viously suggested by abovementioned reports with the
capability of normal RPE to actively pump ions and fluid
out of the subretinal space. RPE regeneration may also
explain the survival of the photoreceptors in patients
with respective ingrowth.
Limitation of this study includes its retrospective design
and the small number of patients which is mainly due to
the fact that this finding is rather rare in contrast to GA.
Conclusion
To summarize, we here present a so far disregarded pres-
entation of AMD with atypical RPE-defects and preserved
overlying photoreceptor-layers over a mean of 4 years.
Affected eyes retained reasonable vision without any
evidence of CNV. Repair mechanisms such as ingrowth of
RPE/drusenoid material, as well as a RPE-independent vis-
ual cycle for cone photopigment within the neurosensory
retina may contribute to the favorable long-term results.
Abbreviations
AMD: Age-related macular degeneration; BCVA: Best corrected visual acuity;
CNV: Choroidal neovascularization; CSC: Central serous chorioretinopathy;
ELM: External limiting membrane; EZ: Ellipsoid zone; FA: Fluorescein
angiography; FAF: Fundus autofluorescence; GA: Geographic atrophy;
ICG: Indocyanine angiography; OCT: Optical coherence tomography;
PED: Pigment epithelium detachment; PR: Photoreceptor; RPE: Retinal
pigment epithelium; SD-OCT: Spectral domain optic coherence tomography;
SRF: Subretinal fluid; VEGF: Vascular endothelial growth factor
Acknowledgement
None.
Funding
No funding was received for this research.
Availability of data and materials
Only aggregated data are provided (mean/average/range) in order to
protect the privacy of the patient.
The datasets generated and/or analysed during the current study are not
publicly available as with such a low patient number as in this cases series,
there would be a significant risk to reveal the identity of the patients. So
aggregated/de-identified data are published. Data would be available from
the corresponding author on reasonable request.
Authors’ contributions
HGZ: writing the draft, interpretation of the data, approving final version; GQ:
collecting data/patients, interpretation of the data, critical review of the
manuscript, approving final version; ICM: collecting data/patients,
interpretation of the data, critical review of the manuscript, approving final
version; DS: collecting data/patients, interpretation of the data, critical review
of the manuscript, approving final version; DaSa: collecting data/patients,
interpretation of the data, critical review of the manuscript, approving final
version; XC: collecting data/patients, interpretation of the data, critical review
of the manuscript, approving final version; ECS: collecting data/patients,
interpretation of the data, critical review of the manuscript, approving final
version; SM: collecting data/patients, interpretation of the data, critical review
of the manuscript, approving final version; VC: collecting data/patients,
interpretation of the data, critical review of the manuscript, approving final
version; MWR: collecting data/patients, interpretation of the data, critical
review of the manuscript, approving final version; CG: collecting data/
patients, interpretation of the data, critical review of the manuscript,
approving final version; AE: collecting data/patients, interpretation of the
data, critical review of the manuscript, approving final version; MSZ:
collecting data/patients, interpretation of the data, critical review of the
manuscript, approving final version; MRM: concept and design, collection of
data/patients, interpretation of data, drafting and correction of manuscript,
approving final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent to publish the data was obtained from each patient.
Ethics approval and consent to participate
The study adhered to the tenets of the Declaration of Helsinki and was
approved by the Ethic committee at Inselspital, University Clinic Bern, IRB
Shroff Eye Center, Institutional Review Board at Manhattan Eye, Ear and
Throat Hospital/Lenox Hill Hospital, the Health Research Ethics Committee
in Region Hovedstaden, Denmark, Institutional Review Board of the
University of California Los Angeles, Ethic Comitee at University of Sao
Paulo, and Institutional Review Board (IRCCS Ospedale San Raffaele,
University Vita-Salute San Raffaele, Milan. Written informed consent to
publish the data was obtained from each patient.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Ophthalmology and Department of Clinical Research,
Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
2Bern Photographic Reading Center, Inselspital, University Clinic Bern, Bern,
Switzerland. 3Department of Ophthalmology, University Vita-Salute, IRCCS
Ospedale San Raffaele, Milan, Italy. 4Department of Ophthalmology,
Giannakaki-Zimmermann et al. BMC Ophthalmology  (2017) 17:67 Page 7 of 8
University Paris Est, CHI, Creteil, France. 5Department of Ophthalmology,
Zealand University Hospital, University of Copenhagen, Copenhagen,
Denmark. 6Shroff Eye Center, New Delhi, India. 7Jules Stein Eye Institute,
UCLA, Los Angeles, CA, USA. 8Greater LA VA Healthcare Center, Los Angeles,
CA, USA. 9University of Sao Paulo, Sao Paulo, Brazil. 10Faculdade de Medicina
de Ribeirão Preto, Ribeirão Preto, Brazil. 11Vitreous Retina Macula Consultants
of New York, New York, USA. 12Department of Ophthalmology, Northwestern
University, Feinberg School of Medicine, Chicago, IL, USA.
Received: 23 February 2017 Accepted: 22 April 2017
References
1. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem
in a new era. Retina. 2007;27(5):523–34.
2. Clemens CR, Eter N. Retinal pigment epithelium tears: risk factors,
mechanism and therapeutic monitoring. Zeitschrift fur Augenheilkunde.
2016;235(1):1–9.
3. Doguizi S, Ozdek S. Pigment epithelial tears associated with anti-VEGF
therapy: incidence, long-term visual outcome, and relationship with
pigment epithelial detachment in age-related macular degeneration. Retina.
2014;34(6):1156–62.
4. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Mechanism of
retinal pigment epithelium tear formation following intravitreal anti-vascular
endothelial growth factor therapy revealed by spectral-domain optical
coherence tomography. Am J Ophthalmol. 2013;156(5):981–8. e982.
5. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium.
Eye (Lond). 1988;2(Pt 1):106–13.
6. Gutfleisch M, Heimes B, Schumacher M, Dietzel M, Lommatzsch A, Bird A,
Pauleikhoff D. Long-term visual outcome of pigment epithelial tears in
association with anti-VEGF therapy of pigment epithelial detachment in
AMD. Eye (Lond). 2011;25(9):1181–6.
7. Goldstein BG, Pavan PR. ‘Blow-outs’ in the retinal pigment epithelium.
Br J Ophthalmol. 1987;71(9):676–81.
8. Bressler NM, Finklestein D, Sunness JS, Maguire AM, Yarian D. Retinal
pigment epithelial tears through the fovea with preservation of good visual
acuity. Arch Ophthalmol. 1990;108(12):1694–7.
9. Sato T, Mrejen S, Kishi S, Freund KB. Subretinal migration of drusenoid
material after a spontaneous retinal pigment epithelial tear. Retin Cases
Brief Rep. 2014;8(2):120–3.
10. Querques G, Capuano V, Costanzo E, Corvi F, Querques L, Introini U, Souied
EH, Bandello F. RETINAL PIGMENT EPITHELIUM APERTURE: a previously
unreported finding in the evolution of avascular pigment epithelium
detachment. Retina. 2016;36 Suppl 1:S65–72.
11. Kroyer K, la Cour M, Larsen M. Dissociation of rod and cone sensitivity by
acute localized retinal pigment epithelium loss. Acta Ophthalmol. 2008;
86(3):338–40.
12. Mukai R, Sato T, Kishi S. Repair mechanism of retinal pigment epithelial tears
in age-related macular degeneration. Retina. 2015;35(3):473–80.
13. Pece A, Vitale L, Milani P, Pierro L. Spontaneous reattachment of the
margins of a macular retinal pigment epithelium tear: optical coherence
tomography documentation of a case. Zeitschrift fur Augenheilkunde.
2010;224(3):159–61.
14. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium.
Br J Ophthalmol. 1981;65(6):417–22.
15. Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of
intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and
treatment (an American Ophthalmological Society thesis). Trans Am
Ophthalmol Soc. 2014;112:142–59.
16. Chan CK, Lin SG. Retinal pigment epithelial tear after ranibizumab therapy
for subfoveal fibrovascular pigment epithelial detachment. Eur J
Ophthalmol. 2007;17(4):674–6.
17. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-associated retinal
pigment epithelial tear using FA and OCT analysis. Retina. 2008;28(9):1265–9.
18. Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Zeimer M, Pauleikhoff D.
Serous pigment epithelial detachment in age-related macular degeneration:
comparison of different treatments. Eye (Lond). 2009;23(12):2163–8.
19. Yoshitani S, Katsura M, Minamoto A, Tsumura K, Tamura H, Hasebe H, Mishima
HK. Retinal pigment epithelial tear involving the fovea with preserved visual
function. Ophthalmic Surg Lasers Imaging. 2003;34(3):217–20.
20. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the
retinal pigment epithelium. Eye (Lond). 1988;2(Pt 5):552–77.
21. Zanzottera EC, Messinger JD, Ach T, Smith RT, Freund KB, Curcio CA. The
project MACULA retinal pigment epithelium grading system for histology
and optical coherence tomography in age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2015;56(5):3253–68.
22. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and
dysfunction in aging and age-related maculopathy. Ageing Res Rev.
2002;1(3):381–96.
23. Bird AC, Phillips RL, Hageman GS. Geographic atrophy: a histopathological
assessment. JAMA ophthalmology. 2014;132(3):338–45.
24. Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP,
Prunte C, Schmidt-Erfurth U. A systematic comparison of spectral-domain
optical coherence tomography and fundus autofluorescence in patients
with geographic atrophy. Ophthalmology. 2011;118(9):1844–51.
25. Sinawat S, Bhoomibunchoo C, Yospaiboon Y. Spontaneous bilateral retinal
pigment epithelium rips with good visual acuity. J Med Assoc Thai. 2014;97
Suppl 10:S115–119.
26. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related
macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(7):1236–49.
27. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human
photoreceptor mosaic: evidence for selective vulnerability of rods in central
retina. Invest Ophthalmol Vis Sci. 1993;34(12):3278–96.
28. Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of
vitamin a in cone-dominant retinas: a novel pathway for visual-pigment
regeneration in daylight. Neuron. 2002;36(1):69–80.
29. Caramoy A, Fauser S, Kirchhof B. Fundus autofluorescence and spectral-
domain optical coherence tomography findings suggesting tissue
remodelling in retinal pigment epithelium tear. Br J Ophthalmol.
2012;96(9):1211–6.
30. Heriot WJ, Machemer R. Pigment epithelial repair. Graefes Arch Clin Exp
Ophthalmol. 1992;230(1):91–100.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Giannakaki-Zimmermann et al. BMC Ophthalmology  (2017) 17:67 Page 8 of 8
